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Veillonella parvula (Veillon and Zuber 1898) Prévot 1933 is the type species of the genus 
Veillonella in the family Veillonellaceae within the order Clostridiales. The species V. parvula 
is of interest because it is frequently isolated from dental plaque in the human oral cavity and 
can cause opportunistic infections. The species is strictly anaerobic and grows as small cocci 
which usually occur in pairs. Veillonellae  are characterized by their unusual metabolism 
which is centered on the activity of the enzyme methylmalonyl-CoA decarboxylase. Strain 
Te3
T, the type strain of the species, was isolated from the human intestinal tract. Here we 
describe the features of this organism, together with the complete genome sequence, and 
annotation. This is the first complete genome sequence of a member of the large clostridial 
family  Veillonellaceae, and the 2,132,142 bp long single replicon genome with its 1,859 
protein-coding and 61 RNA genes is part of the Genomic  Encyclopedia of  Bacteria and 
Archaea project. 
Introduction
Strain Prévot Te3T (= DSM 2008 = ATCC 10790 = 
JCM 12972) is the type strain of the species 
Veillonella parvula and was first described in 1898 
by Veillon and Zuber [1] as “Staphylococcus 
parvulus” before it was renamed as Veillonella 
parvula  by Prévot in 1933 [2]. Although it is a 
Gram-negative organism harboring lipopoly-
saccharide [3] it is more closely related to Gram-
positive species like Sporomusa, Megasphaera or 
Selenomonas. Together, they share the unusual 
presence of cadaverine and putrescine in their cell 
walls [4]. The genus Veillonella  comprises 11 
species (status July 2009) which are all known to 
inhabit the oral cavity and the gastrointestinal 
tract of homeothermic vertebrates. Six of the 
species, among them V. parvula, have been 
isolated from man, the others are typical for 
rodents [5]. In general, veillonellae are harmless 
inhabitants of most body cavities, however, 
occasionally they can participate in multispecies Gronow et al. 
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infections at diverse body sites and in rare cases 
cause severe infections also as pure cultures [6]. 
Here we present a summary classification and a 
set of features for V. parvula Te3T, together with 
the description of the complete genomic 
sequencing and annotation. 
Classification and features 
The natural habitat is human dental plaque and V. 
parvula can amount to up to 98% of the cultivable 
veillonellae in healthy subgingival sites [7]. 
Additionally, veillonellae are common inhabitants 
of the gastrointestinal tract. Although the other 
species of the genus Veillonella are found in large 
numbers throughout the oral cavity, V. parvula is 
the only species of the genus involved in oral 
diseases such as gingivitis. It has also been 
isolated in rare cases of endocarditis, meningitis, 
discitis [8] or bacteremia as pure culture but more 
often  V. parvula  is involved in multispecies 
infections (reviewed in [6]). Medline indexes few 
cultivated strains with a high degree of 16S rRNA 
gene sequence similarity to Te3T, e.g. DJF_B315 
from porcine intestine (EU728725, Hojberg and 
Jensen, unpublished, 99.9% identity). The other 
type strains of the genus Veillonella  vary from 
94.1% (V. ratti) to 99.2% (V. dispar). A vast 
number of phylotypes with significant 16S rRNA 
sequence similarity to V. parvula were observed 
from intubated patients [9], carious dentine from 
advanced caries (AY995757; 99.7% identity), and 
the human skin microbiome [10]. Curiously, only 
one sample from a human gut metagenome 
analysis [11] scored above 96% sequence 
similarity in screenings of environmental samples 
(status September 2009). 
Figure 1 shows the phylogenetic neighborhood of 
V. parvula strain Te3T in a 16S rRNA based tree. 
The sequences of the four copies of the 16S rRNA 
gene in the genome differ by up to seven 
nucleotides, and differ by up to four nucleotides 
from the previously published sequence 
generated from ATCC 10790 (AY995767). 
 
 
Figure 1. Phylogenetic tree highlighting the position of V. parvula strain Te3
T relative to all other type strains within 
the genus Veillonella. The tree was inferred from 1,378 aligned characters [12,13] of the 16S rRNA gene sequence 
under the maximum likelihood criterion [14]. The tree was rooted with the type strains of other genera within the 
family Veillonellaceae. The branches are scaled in terms of the expected number of substitutions per site. Numbers 
above branches are support values from 1,000 bootstrap replicates if greater than 60%. Lineages with type strain 
genome sequencing projects registered in GOLD [15] are shown in blue, published genomes in bold. 
V. parvula  is a Gram-negative, non-motile, non-
sporeforming, anaerobic coccus (approximately 
0.3 to 0.5 µm in diameter) that grows in pairs or 
short chains (Table 1 and Figure 2). Veillonellae 
are characterized by an unusual metabolism using 
methylmalonyl-CoA decarboxylase to convert the 
free energy derived from decarboxylation 
reactions into an electrochemical gradient of 
sodium ions [29]. They utilize the metabolic end 
products of co-existing carbohydrate-fermenting Veillonella parvula type strain (Te3T) 
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bacteria, i.e. lactic acid bacteria in the 
gastrointestinal tract, and thereby play an 
important role in a natural microbial food chain 
[6]. Another characteristic trait of veillonellae is 
their ability to form intergeneric coaggregates 
with other  bacteria which occur in the same 
ecological niche [30]. Although Veillonella cannot 
adhere to surfaces itself, the bacterium is able to 
attach to specific surface structures present on 
other cells, often mediated by lectin-carbohydrate 
interactions [31].  The coaggregation creates a 
functional community providing nutrients and 
protection for all participants. 
Strain Te3T  produces propionic and acetic acid, 
carbon dioxide and hydrogen from lactate and 
other organic acids like pyruvate, malate or 
fumarate. V. parvula cannot grow on succinate as a 
sole carbon source but can decarboxylate 
succinate during fermentation of lactate or malate 
[25]. Veillonellae are unable to use glucose or 
other carbohydrates for fermentation [26] and 
they do not possess a functional hexokinase [24]. 
Nitrate is reduced and arginine dihydrolase is 
produced. 
Veillonellae show resistance to tetracycline (>25 
µg/ml), erythromycin (>25 µg/ml) gentamicin 
(>25 µg/ml) and kanamycin (>25 µg/ml) and they 
are susceptible to penicillin G (0.4 µg/ml), 
cephalotin (1.6 µg/ml) and clindamycin (0.1 
µg/ml). Their resistance is intermediate for 
chloramphenicol (3.1 µg/ml) and lincomycin (6.2 
µg/ml) [32]. 
Chemotaxonomy 
The cell wall of V. parvula  comprises an outer 
membrane, clearly demonstrating the presence of 
lipopolysaccharide [33]. The peptidoglycan of 
veillonellae is of the A1γ-type with glutamic acid 
in D configuration, diaminopimelic acid in meso 
configuration and covalently bound cadaverine or 
putrescine attached in α-linkage to glutamic acid 
[34]. As major fatty acids straight-chain saturated 
C13:0  (24%), C15:0  (12%) and C16:0  (7%) and 
unsaturated C16:1 (5%), C17:1 (22%) and C18:1 (6%) 
are synthesized [35]. Another characteristic 
feature of V. parvula  is the presence of 
plasmalogens such as plasmenylethanolamine and 
plasmenylserine as major constituents of the 
cytoplasmic membrane. These ether lipids replace 
phospholipids and play an important role in the 
regulation of membrane fluidity [36]. 
 
 
Figure 2. Scanning electron micrograph of V. parvula Te3
T Gronow et al. 
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Table 1. Classification and general features of V. parvula Te3
T according to the MIGS recommendations [16]. 
MIGS ID  Property  Term  Evidence code 
 
Current classification 
 
Domain Bacteria  TAS [17] 
Phylum Firmicutes  TAS [18,19] 
Class Clostridia  TAS [18] 
Order Clostridiales  TAS [20,21] 
Family Veillonellaceae  TAS [22,23] 
Genus Veillonella  TAS [2] 
Species Veillonella parvula  TAS [2] 
Type strain Te3  TAS [2] 
  Gram stain  negative  TAS [1] 
  Cell shape  small cocci  TAS [1] 
  Motility  nonmotile  TAS [1] 
  Sporulation  nonsporulating  TAS [1] 
  Temperature range  mesophile  TAS [1] 
  Optimum temperature  37°C  TAS [1] 
  Salinity  normal  TAS [1] 
MIGS-22  Oxygen requirement  anaerobic  TAS [1] 
  Carbon source  acid production from lactate and other 
organic acids 
TAS [24] 
  Energy source  lactate; succinate  TAS [25,26] 
MIGS-6  Habitat  human gastrointestinal tract  TAS [1] 
MIGS-15  Biotic relationship  human pathogen  TAS [1] 
MIGS-14  Pathogenicity  subgingival plaque formation; opportunistic 
pathogen 
TAS [1] 
  Biosafety level  2  TAS [27] 
  Isolation  human intestinal tract  TAS [1] 
MIGS-4  Geographic location  unknown, probably France  TAS [1] 
MIGS-5  Sample collection time  before 1898  TAS [1] 
MIGS-4.1 
MIGS-4.2 
Latitude, Longitude  unknown   
MIGS-4.3  Depth  not reported   
MIGS-4.4  Altitude  not reported   
Evidence codes -  IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author 
Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not 
directly observed for the living, isolated sample, but based on a generally accepted property for the species, 
or anecdotal evidence). These evidence codes are from of the Gene Ontology project [28]. If the evidence 
code is IDA, then the property was observed for a live isolate by one of the authors or an expert mentioned 
in the acknowledgements. 
Genome sequencing and annotation 
Genome project history 
This organism was selected for sequencing on the 
basis of its phylogenetic position, and is part of the 
Genomic  Encyclopedia of  Bacteria and  Archaea 
project. The genome project is deposited in the 
Genome OnLine Database [15] and the complete 
genome sequence is deposited in GenBank. 
Sequencing, finishing and annotation were 
performed by the DOE Joint Genome Institute 
(JGI). A summary of the project information is 
shown in Table 2. 
Growth conditions and DNA isolation 
V. parvula  strain Te3T, DSM 2008, was grown 
anaerobically in DSMZ medium 104 (modified 
PYG-Medium, with the addition of lactate and 
putrescine) at 37°C [37]. DNA was isolated from 
1.5-2 g of cell paste using Qiagen Genomic 500 
DNA Kit (Qiagen, Hilden, Germany) following the 
manufacturer’s protocol, with cell lysis protocol L 
as described in Wu et al. [38]. Veillonella parvula type strain (Te3T) 
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Table 2. Genome sequencing project information 
MIGS ID  Property  Term 
MIGS-31  Finishing quality  Finished 
MIGS-28 
Libraries used  Two Sanger libraries: 8kb pMCL200 and fosmid pcc1Fos 
One 454 pyrosequence standard library 
MIGS-29  Sequencing platforms  ABI3730, 454 GS FLX 
MIGS-31.2  Sequencing coverage  7.67× Sanger; 50.6× pyrosequence 
MIGS-30  Assemblers  Newbler, Phrap 
MIGS-32  Gene calling method  Prodigal, GenePRIMP 
  INSDC ID  CP001820 
  Genbank Date of Release  November, 23 2009 
  GOLD ID  Gc01152 
  NCBI project ID  21091 
  Database: IMG-GEBA  2501651195 
MIGS-13  Source material identifier  DSM 2008 
  Project relevance  Tree of Life, GEBA 
 
Genome sequencing and assembly 
The genome was sequenced using a combination 
of Sanger and 454 sequencing platforms. All 
general aspects of library construction and 
sequencing performed at the JGI can be found at 
http://www.jgi.doe.gov/. 454 Pyrosequencing 
reads were assembled using the Newbler 
assembler version 1.1.02.15 (Roche). Large 
Newbler contigs were broken into 1,716 
overlapping fragments of 1,000 bp and entered 
into assembly as pseudo-reads. The sequences 
were assigned  quality scores based on Newbler 
consensus q-scores with modifications to account 
for overlap redundancy and to adjust inflated q-
scores. A hybrid 454/Sanger assembly was made 
using the parallel phrap assembler (High 
Performance Software, LLC). Possible mis-
assemblies were corrected with Dupfinisher [39] 
or transposon bombing of bridging clones 
(Epicentre Biotechnologies, Madison, WI). Gaps 
between contigs were closed by editing in Consed, 
custom primer walk or PCR amplification. A total 
of 1,082 Sanger finishing reads were produced to 
close gaps, to resolve repetitive regions, and to 
raise the quality of the finished sequence. The 
error rate of the completed genome sequence is 
less than 1 in 100,000. Together all sequence 
types provided 51.2× coverage of the genome. The 
final assembly contains 16,169 Sanger and 
445,271 pyrosequence reads. 
Genome annotation 
Genes were identified using Prodigal [40] as part 
of the Oak Ridge National Laboratory genome 
annotation pipeline, followed by a round of 
manual curation using the JGI GenePRIMP pipeline 
(http://geneprimp.jgi-psf.org) [41]. The predicted 
CDSs were translated and used to search the 
National Center for Biotechnology Information 
(NCBI) nonredundant database, UniProt, 
TIGRFam, Pfam, PRIAM, KEGG, COG, and InterPro 
databases. Additional gene prediction analysis and 
functional annotation were performed within the 
Integrated Microbial Genomes Expert Review 
(IMG-ER) platform (http://img.jgi.doe.gov/er) 
[42]. 
Genome properties 
The genome is 2,132,142 bp long and comprises 
one main circular chromosome with a 38.6% GC 
content (Table 3 and Figure 3). Of the 1,920 genes 
predicted, 1,859 were protein coding genes, and 
61 RNAs;  15  pseudogenes were also identified. 
The majority (73.6%) of the genes were assigned 
a putative function while those remaining were 
annotated as hypothetical proteins. The distri-
bution of genes into COGs functional categories is 
presented in Table 4. 
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Table 3. Genome Statistics 
Attribute  Value  % of Total 
Genome size (bp)  2,132,142  100.00% 
DNA coding region (bp)  1,886,054  88.46% 
DNA G+C content (bp)  823,631  38.63% 
Number of replicons  1   
Extrachromosomal elements  0   
Total genes  1,920  100.00% 
RNA genes  61  3.18% 
rRNA operons  4   
Protein-coding genes  1,859  96.82% 
Pseudo genes  15  0.78% 
Genes with function prediction  1,413  73.59% 
Genes in paralog clusters  174  9.06% 
Genes assigned to COGs  1,474  76.77% 
Genes assigned Pfam domains  1,490  77.06% 
Genes with signal peptides  306  15.94% 
Genes with transmembrane helices  492  25.62% 
CRISPR repeats  5   
 
 
Figure 3. Graphical circular map of the genome. From outside to the center: 
Genes on forward strand (color by COG categories), Genes on reverse strand 
(color by COG categories), RNA genes (tRNAs green, rRNAs red, other RNAs 
black), GC content, GC skew. Veillonella parvula type strain (Te3T) 
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Table 4. Number of genes associated with the general COG functional categories 
Code  value  %age  Description 
J  142  7.6  Translation, ribosomal structure and biogenesis 
A  0  0.0  RNA processing and modification 
K  71  3.8  Transcription 
L  92  4.9  Replication, recombination and repair 
B  2  0.1  Chromatin structure and dynamics 
D  20  1.1  Cell cycle control, mitosis and meiosis 
Y  0  0.0  Nuclear structure 
V  26  1.4  Defense mechanisms 
T  29  1.6  Signal transduction mechanisms 
M  106  5.7  Cell wall/membrane biogenesis 
N  6  0.3  Cell motility 
Z  0  0.0  Cytoskeleton 
W  0  0.0  Extracellular structures 
U  35  1.9  Intracellular trafficking and secretion 
O  48  2.6  Posttranslational modification, protein turnover, chaperones 
C  100  5.4  Energy production and conversion 
G  68  3.6  Carbohydrate transport and metabolism 
E  160  8.6  Amino acid transport and metabolism 
F  63  3.4  Nucleotide transport and metabolism 
H  117  6.3  Coenzyme transport and metabolism 
I  33  1.8  Lipid transport and metabolism 
P  124  6.7  Inorganic ion transport and metabolism 
Q  19  1.8  Secondary metabolites biosynthesis, transport and catabolism 
R  177  9.5  General function prediction only 
S  143  7.7  Function unknown 
-  385  20.7  Not in COGs 
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